Abstract:Background: Coronary artery disease is caused by changes in the coronary arteries due to the atherosclerotic process and thrombotic changes. A very important role in the development of the atherosclerotic process in the coronary vessels is played by the inflammatory process and the immune response. Due to the important role of lipids and the coagulation process in the atherosclerotic process, research has also focused on genes affecting lipid metabolism and the coagulation system. Lipoprotein lipase (LPL) is an enzyme that metabolises lipids, hydrolysing triglycerides to produce free fatty acids and glycerol. Protein C (PC) is an essential component of coagulation and fibrinolysis. It is activated on the endothelial surface by the membrane-bound thrombin-thrombomodulin complex. Platelet-derived growth factor (PDGF) has a number of important functions in processes related to fibroblast and smooth muscle cell function. Due to their influence on lipid metabolism and coagulation processes, LPL, PROCR (endothelial cell protein C receptor) and PDGF may affect the atherosclerotic process and, thus, the risk of coronary heart disease. The aim of the study was to examine the associations between the LPL rs264, PROCR rs867186 and PDGF rs974819 gene polymorphisms and the risk of unstable angina and selected clinical parameters. Methods: The study included 232 patients with unstable angina and 144 healthy subjects as the control group. Genotyping was performed using real-time PCR. Results: There were no statistically significant differences in the distribution of the polymorphisms tested between the patients with unstable angina and the control subjects. The results showed associations between the PROCR rs867186 and PDGF rs974819 polymorphisms and some clinical parameters in patients with unstable angina. In patients with the PDGF rs974819 CC genotype, there were increased values for cholesterol and LDL serum levels in comparison with patients with the PDGF rs974819 CT and TT genotypes. In patients with the PROCR rs867186 AA genotype, HDL serum levels were lower than in patients with the GA genotype. Conclusions: The results of our study did not show that the LPL rs264, PROCR rs867186 and PDGF rs974819 gene polymorphisms were significant risk factors for unstable angina in our population. The results of the study suggest that PDGF rs974819 and PROCR rs867186 may be associated with some parameters of lipid metabolism.

What problem does this paper attempt to address?

This paper attempts to explore the associations between the gene polymorphisms of LPL rs264, PROCR rs867186 and PDGF rs974819 and the risk of patients with unstable angina pectoris as well as some clinical parameters. Specifically, the researchers hope to evaluate whether these gene variants may be genetic risk factors for unstable angina pectoris by analyzing the distribution differences of these gene polymorphisms between patients with unstable angina pectoris and healthy control groups, and their relationships with clinical parameters such as blood lipid levels. ### Research Background Coronary artery disease is caused by coronary atherosclerosis and thrombosis. Inflammatory processes and immune responses play important roles in the occurrence and development of coronary atherosclerosis. Gene polymorphisms in lipid metabolism and the coagulation system are considered potential risk factors for coronary artery disease. Due to their effects on lipid metabolism and the coagulation process, the LPL (lipoprotein lipase), PROCR (endothelial protein C receptor) and PDGF (platelet - derived growth factor) genes may affect the development of atherosclerosis, thereby affecting the risk of coronary heart disease. ### Research Objectives The main objective of the study is to investigate the relationships between the gene polymorphisms of LPL rs264, PROCR rs867186 and PDGF rs974819 and the risk of unstable angina pectoris as well as selected clinical parameters. ### Methods The study included 232 patients with unstable angina pectoris and 144 healthy control groups. Genotyping was performed by real - time PCR technology. Statistical analysis used methods such as chi - square test, Fisher's exact test and Mann - Whitney U test. ### Results - **Distribution of Gene Polymorphisms**: There were no significant differences in the distributions of LPL rs264 and PDGF rs974819 gene polymorphisms between patients with unstable angina pectoris and healthy control groups. There were significant differences in the distribution of PROCR rs867186 gene polymorphisms, but this result was not verified by Fisher's exact test or allele analysis. - **Associations with Clinical Parameters**: - Patients carrying the PDGF rs974819 CC genotype had higher total cholesterol and low - density lipoprotein (LDL) levels. - Patients carrying the PROCR rs867186 AA genotype had lower high - density lipoprotein (HDL) levels. - Patients carrying the LPL rs264 AG genotype had lower HDL levels. ### Discussion Although the study found some associations between gene polymorphisms and clinical parameters, after applying the Bonferroni correction, none of these associations reached statistical significance. Therefore, these results should be interpreted with caution. The study also pointed out that the small sample size and the limitation of the study population to a single department are the limitations of this study, and further large - scale studies are needed to verify these findings. ### Conclusion The results of the study indicate that the gene polymorphisms of LPL rs264, PROCR rs867186 and PDGF rs974819 are not significant genetic risk factors for unstable angina pectoris in the studied population. However, PDGF rs974819 and PROCR rs867186 may be related to some lipid metabolism parameters.

LPL rs264, PROCR rs867186 and PDGF rs974819 Gene Polymorphisms in Patients with Unstable Angina

Association Between Polymorphisms of Inflammatory Factor Genes and Coronary Heart Disease

Association Between Peroxisome Proliferator-Activated Receptor-Alpha, Delta, and Gamma Polymorphisms and Risk of Coronary Heart Disease A Case-Control Study and Meta-Analysis

Candidate Gene and Pathway Analyses Identifying Genetic Variations Associated with Prasugrel Pharmacokinetics and Pharmacodynamics.

The impact of gene polymorphism and high on-treatment platelet reactivity on clinical follow-up: outcomes in patients with acute coronary syndrome after drug-eluting stent implantation.

Roles of endothelial lipase gene related single nucleotide polymorphisms in patients with coronary artery disease

ANRIL polymorphisms (rs1333049 and rs3217992) in relation to plasma CRP levels among in-patients with CHD

Association Of Genetic Polymorphisms In The Fibrinogen And Platelet Glycoprotein Genes With Unstable Angina In Chinese Patients

The impact of residual platelet activity and CYP2C19 polymorphism on the prognosis of acute coronary syndrome patients

Association between lipoprotein-associated phospholipase A2 gene Val279Phe homozygous genotypes and variant angina in Japanese women

The impact of PEAR1 gene polymorphisms on outcomes of acute coronary syndrome patients

Study of the Association of PEAR1, P2Y12, and UGT2A1 Polymorphisms with Platelet Reactivity in Response to Dual Antiplatelet Therapy in Chinese Patients.

Interleukin 6 polymorphisms are associated with cardiovascular risk factors in premature coronary artery disease patients and healthy controls of the GEA Mexican study

Polymorphism rs662 (Q192R) of paraoxonase-1 and susceptibility to atherosclerosis of the coronary arteries

Clopidogrel‐associated Genetic Variants on Inhibition of Platelet Activity and Clinical Outcome for Acute Coronary Syndrome Patients

Genetic Mutations in PEAR1 Associated with Cardiovascular Outcomes in Chinese Patients with Acute Coronary Syndrome

Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease

Renin-Angiotensin-Aldosterone System Gene Polymorphisms and Coronary Artery Disease: Detection of Gene-Gene and Gene-Environment Interactions

The influence of P2Y12 gene polymorphisms on clopidogrel therapy in patients after percutaneous coronary intervention

Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease

Haplotype of the Lipoprotein(a) Gene Variants rs10455872 and rs3798220 Is Associated with Parameters of Coagulation, Fibrinolysis, and Inflammation in Patients after Myocardial Infarction and Highly Elevated Lipoprotein(a) Values